Regenerative interventions work by challenging tissue. Biostimulatory injectables activate fibroblasts and drive collagen synthesis. Energy-based devices create controlled thermal injury that the body is expected to repair. Photobiomodulation stimulates the mitochondrial system directly. In each case, the quality of the outcome depends not only on the treatment itself, but on the cellular capacity to respond to it. That capacity is, at its root, a mitochondrial question. 

Despite advances in regenerative treatments, clinicians continue to observe considerable variation in patient responses, even when similar protocols are used. This raises an important question: are we focusing enough on the biological environment into which we are treating? It is worth stating at the outset that the direct clinical evidence linking mitochondrial optimisation to aesthetic outcomes is still developing; the argument here rests on well-established mechanistic biology. 

Where this started: connecting light and nutrition 

Mitochondria are organelles found in nearly every cell in the body, traditionally described as the cell’s power plants because of their role in producing adenosine triphosphate (ATP). Their function extends substantially beyond energy production: they regulate oxidative stress, inflammatory signalling, calcium balance and cellular repair.1 For regenerative practice, where the goal is to stimulate precisely these repair processes, the mitochondrial system is the relevant biological substrate. 

My route into mitochondrial biology came through light therapy, specifically, years spent designing photobiomodulation devices, where the mechanism of action is mitochondrial by definition. Photobiomodulation acts primarily on cytochrome c oxidase, a protein complex in the mitochondrial electron transport chain. Red and near-infrared photons displace nitric oxide bound to cytochrome c oxidase, removing a key inhibitory signal on the chain and increasing ATP production.2 

Photobiomodulation also follows a biphasic dose-response curve: there is an optimal therapeutic window, and beyond a certain dose, additional light produces diminishing returns. The conventional explanation is that excessive stimulation generates more reactive oxygen species (ROS) than the cell can manage.3,4 One hypothesis, which has not yet been formally tested, is that the biphasic response also reflects cofactor availability. There is now human evidence that light-driven mitochondria increase glucose consumption systemically: a single 15-minute exposure of red light to the skin has been shown to measurably reduce post-meal blood glucose in healthy volunteers.5 Because glucose oxidation and the cycling of NAD+ and CoQ10 are coupled in the same energy-producing pathway, it is a reasonable extension, though not yet directly tested, that upregulated glucose consumption comes with a matching increase in cofactor turnover. If those reserves are drawn down faster than they are replenished, the same stimulation that initially supported function instead drives oxidative stress. 

This is what made the connection between light-based and nutritional interventions clinically meaningful. They are typically treated as separate fields, but they converge on the same biology, and they reinforce each other. The question this raises, and the one this article addresses, is what determines the metabolic environment we are treating into, and how much of the outcome is shaped by it before we begin? 

The conveyor belt and the concept of redox balance 

Mitochondrial energy production works rather like a conveyor belt. The electron transport chain, a series of protein complexes in the inner mitochondrial membrane, moves electrons through a sequence of reactions that ultimately generate ATP.1 Like any system that converts energy, it produces a by-product. In electrical systems there are always efficiency trade-offs; energy lost as heat, energy lost as friction, energy lost as noise. In biological energy production, a trade-off is ROS: molecules generated when electrons leak from the chain and react with oxygen.6 

At low to moderate levels, ROS are not damage. They are signals, telling the cell that energy demand is high, that adaptation is needed.7 But when ROS accumulate faster than antioxidant systems can manage, the balance tips into oxidative stress. This is the concept of redox balance: the dynamic equilibrium between oxidising species and the cellular reducing capacity that contains them. Redox balance is not the elimination of oxidation; it is the maintenance of a state in which oxidation can do useful signalling work without overwhelming the system. It is the central organising principle of mitochondrial health.8 

This reframes how mitochondria should be supported. Not stimulated to maximum output, not protected from all oxidative challenge, but kept in balance and, in a meaningful sense, trained. A mitochondrion that is never challenged does not adapt. A mitochondrion chronically overwhelmed degrades. The goal is the space in between: sufficient challenge to drive adaptation, sufficient recovery to allow repair. This principle is hormesis: biological systems improve through cycles of controlled stress and adequate recovery.9 It is the same principle that makes exercise beneficial and the same one that, taken too far in either direction, produces a deconditioned cell that has lost its stimulus to adapt. 

The missing piece: mitochondria behave differently across the day 

Mitochondria do not produce energy on demand. They operate on a 24-hour rhythm, shifting their priorities, enzyme activities and structural morphology across the day-night cycle.10 During the day, the system is configured for output: mitochondria fuse into elongated networks that maximise the membrane surface area for electron transport, and the chain runs at high throughput. NAD+ levels are elevated, driving sirtuin activity and supporting the metabolic demands of waking physiology. The elevated ROS produced during this phase serves an adaptive function, activating NRF2, AMPK and PGC-1α pathways that drive biogenesis.7,11 

As light levels fall and melatonin rises, the programme shifts. ETC activity downregulates. The elongated daytime networks fragment into smaller units to support mitophagy, the selective clearance of damaged mitochondria.7 The system enters an active maintenance phase: accumulated damage is cleared, antioxidants are recycled, membranes are repaired, and the conditions for new mitochondrial biogenesis are established.11 This is a metabolically demanding programme that requires its own specific inputs. 

One potential clinical implication concerns this overnight repair window. Mitophagy is integral to tissue repair, maintaining a functional mitochondrial pool as healing proceeds; when the night-time maintenance phase is repeatedly curtailed, the conditions for that repair are compromised.12,13,14 Experimental sleep restriction delays skin-barrier recovery and blunts the local immune response at the wound site, and where poor sleep is chronic, as it is for a significant proportion of patients in aesthetic clinics, the cumulative toll on mitochondrial function and regenerative capacity is likely to be meaningful.15 

What this means for regenerative practice 

Dermal fibroblasts, the cells responsible for producing collagen and elastin, are among the most mitochondrially active in the body. Collagen synthesis is an ATP-intensive process, as are cell division, matrix remodelling, and the controlled inflammatory response that follows tissue challenge.16 

As mitochondrial function declines with age, this capacity diminishes. Studies have reported reductions in mitochondrial respiratory capacity of approximately 8-10% per decade from age 30.17 NAD+, the substrate for mitochondrial redox reactions and sirtuin signalling, also declines with age, a pattern reported in both skin tissue and plasma, though the reported magnitude varies with the compartment measured and the intracellular pool most relevant to mitochondrial function is harder to quantify than circulating NAD+.18,19 These changes have direct relevance for the regenerative response: tissue that enters treatment with depleted mitochondrial capacity is asked to do the same work with fewer resources. 

This raises an underexplored question in aesthetic practice: when treating a patient, what is the metabolic environment we are treating into, and what determines whether the tissue can mount the regenerative response we are asking of it? The circadian framework, and the redox principles described above, offer a more precise way to think about how that environment is shaped and how it can be supported. 

The antioxidant timing problem 

The instinct in the supplement space is that more antioxidant protection is always better. The redox biology suggests otherwise. Research has shown that high-dose antioxidant supplementation taken during or immediately after exercise can blunt the adaptive response, suppressing the redox signal before the cell can act on it.20 

If daytime ROS are flattened too aggressively, the stimulus for biogenesis and repair is reduced, the system is pushed too far toward the reductive end, and the result is a deconditioned cell. By contrast, overnight antioxidant support may help sustain a repair programme already underway. The same intervention has different effects depending on when it is delivered. 

The mechanisms that determine mitochondrial efficiency 

Mitochondrial function depends on the coordinated performance of several interconnected systems, including electron transport, membrane potential, biogenesis signalling and antioxidant defence. A deficit in any one of these pathways can limit the performance of the others.1 Rather than asking which single supplement supports mitochondrial function, it is more useful to consider the key biological pathways that underpin mitochondrial function and how they contribute to regenerative capacity. 

NAD+ 

NAD+ is central to mitochondrial energy metabolism and to the sirtuin enzymes that regulate gene expression and DNA repair.21 Levels decline substantially with age, and precursors such as NMN have been shown to restore NAD+ availability, with clinical evidence including improvements in muscle insulin sensitivity in prediabetic postmenopausal women at clinically relevant doses.22 Because NAD+ oscillates across the circadian cycle, supplementation timing matters. 

CoQ10 and the electron transport chain 

CoQ10 is the carrier that physically moves electrons between the protein complexes of the chain. When CoQ10 is depleted, electron transfer slows, ATP output falls, and electron leak generates more ROS.23 Supporting CoQ10 maintains the efficiency of the chain, not just its output. 

Membrane integrity 

ATP is generated as protons flow back across the inner mitochondrial membrane through ATP synthase. ATP is biologically utilised as its magnesium complex, so magnesium is a prerequisite for ATP to function, as well as a cofactor for ATP synthase and hundreds of other mitochondrial reactions.24 Without adequate membrane support, the upstream investment in electron carriers does not translate into useful energy output. 

Biogenesis 

Mitochondrial biogenesis is regulated through PGC-1α, activated by both AMPK and SIRT1.25  The signals that trigger biogenesis include the controlled ROS generated during periods of metabolic demand, which is why suppressing daytime ROS undermines the stimulus. PQQ stimulates this pathway in preclinical models, with human data showing increased biogenesis markers but no demonstrated functional gain,26 and resveratrol is reported to activate SIRT1, likely indirectly.27,28 

The antioxidant network and redox maintenance 

The body’s primary antioxidant defences are enzymatic, superoxide dismutase, glutathione peroxidase and catalase. Superoxide dismutase and glutathione peroxidase depend on trace mineral cofactors including selenium, manganese, zinc and copper, while catalase is a heme (iron)-dependent enzyme.29 Exogenous antioxidants such as vitamin C, alpha-lipoic acid and astaxanthin provide additional support, particularly in the overnight recycling cascade, but the enzymatic systems do the heaviest lifting in maintaining redox state.30 

Structural substrates 

The regenerative outcomes that follow mitochondrial activation depend on structural inputs that mitochondrial discussions often overlook. Collagen synthesis requires vitamin C for hydroxylation, zinc for wound repair signalling, and copper for elastin cross-linking. Their availability shapes the quality of the regenerative response. 

Applying in practice 

With that caveat in mind, the mechanistic basis is well-established, and several practical implications follow. 

First, the cellular environment a patient brings to treatment is a relevant variable. Sleep quality, light exposure patterns, chronic stress and nutritional status are direct inputs to mitochondrial function. Brief screening of these during consultation surfaces meaningful information about regenerative readiness. 

Second, pre-treatment optimisation deserves consideration, particularly for patients with variable or underwhelming responses to previous procedures. A period of focused nutritional support in the weeks before elective procedures may improve the baseline cellular environment into which the treatment is delivered. 

Third, exercise is the most established intervention for supporting mitochondrial function. VO2 max is one of the strongest functional markers linked to long-term mitochondrial health and metabolic fitness.31 For aesthetic patients, encouraging consistent physical activity is one of the few interventions with substantial evidence for improving the underlying cellular environment. 

Fourth, supporting sleep quality, including practical guidance on evening light exposure, protects the overnight repair phase in which much of the post-treatment restoration actually occurs.11,13 

Finally, the antioxidant timing principle has practical implications for supplementation. A broad-spectrum antioxidant taken throughout the day is not biologically optimal. Separating daytime support, calibrated to protect without suppressing adaptive ROS signalling, from more comprehensive overnight support is a more informed approach.20 

The MV-SYSTEM® was developed around this principle, with products designed for AM and PM to complement circadian biology. I have a commercial interest, disclosed below, but the underlying logic stands independently of any specific product. 

Conclusion 

Mitochondria are not passive energy producers. They are dynamic systems that require challenge and recovery in balance, that operate differently across the day and night, and that depend on a coordinated network of biochemical inputs to function well. For practitioners in regenerative aesthetics, this offers a biologically grounded way to think about the cellular environment in which every treatment takes place. 

As regenerative medicine continues to focus on stimulating repair, an equally important question emerges: how capable is the cell of responding to that stimulus? Mitochondrial health may prove to be one of the most important determinants of treatment outcomes in the decade ahead. A useful next step would be prospective studies correlating baseline mitochondrial markers with measured regenerative outcomes, moving the field from mechanistic plausibility toward direct clinical evidence. 

Disclosure: Ben Rawlings is CEO and Co-Founder of Mitovitality® Ltd; a wellness company that has developed the MV-SYSTEM® nutritional protocol referenced in this article.